Magnetic resonance imaging and spectroscopy in multiple sclerosis

Area of Science:

• Neurology
• Radiology
• Medical Imaging

Background:

• Interferon beta has shown significant effects on magnetic resonance imaging (MRI)-detected disease activity in multiple sclerosis (MS).
• There is a growing interest in utilizing MRI for monitoring treatment efficacy in MS.
• Effective treatment monitoring requires sensitive and accurate detection of disease activity with findings predictive of clinical outcomes, particularly disability.

Purpose of the Study:

• To review the advancements and potential of magnetic resonance imaging (MRI) techniques in monitoring multiple sclerosis (MS) treatment.
• To highlight newer MRI methods that offer improved sensitivity and pathological specificity compared to conventional sequences.
• To discuss the role of advanced MRI in understanding MS pathophysiology and predicting clinical disability.

Main Methods:

• Review of recent developments in magnetic resonance imaging (MRI) for multiple sclerosis (MS) monitoring.
• Comparison of conventional T2-weighted MRI sequences with emerging techniques.
• Discussion of advanced MRI methods such as magnetization transfer imaging and MRI spectroscopy.

Main Results:

• Several novel MRI approaches demonstrate higher sensitivity than conventional T2-weighted sequences for detecting MS disease activity.
• Newer MRI techniques like magnetization transfer imaging and MRI spectroscopy can identify pathological substrates of disability, such as demyelination and axonal loss, which are missed by conventional MRI.
• Improved methods for visualizing spinal cord lesions in MS have been developed.

Conclusions:

• Advanced magnetic resonance imaging (MRI) techniques are crucial for sensitive and specific monitoring of multiple sclerosis (MS) treatment.
• These newer MRI methods provide deeper insights into MS pathophysiology and hold promise for predicting irreversible disability.
• Developments in MRI, including those focused on the spinal cord, are enhancing the comprehensive assessment of MS.